SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-332707
Filing Date
2013-08-13
Accepted
2013-08-13 16:06:55
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d544903d10q.htm 10-Q 637121
2 EX-31.1 d544903dex311.htm EX-31.1 9310
3 EX-31.2 d544903dex312.htm EX-31.2 9310
4 EX-32.1 d544903dex321.htm EX-32.1 3474
5 EX-32.2 d544903dex322.htm EX-32.2 3477
  Complete submission text file 0001193125-13-332707.txt   6456642

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT petx-20130630.xml EX-101.INS 623620
7 XBRL TAXONOMY EXTENSION SCHEMA petx-20130630.xsd EX-101.SCH 45751
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE petx-20130630_cal.xml EX-101.CAL 61083
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE petx-20130630_def.xml EX-101.DEF 163236
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE petx-20130630_lab.xml EX-101.LAB 315118
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE petx-20130630_pre.xml EX-101.PRE 243252
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 131033146
SIC: 2834 Pharmaceutical Preparations